Isomorphic Labs Ltd., an Alphabet Inc. spinoff working to accelerate drug discovery, is said to be raising a new funding round. The Bloomberg report that revealed the discussions today didn’t specify the size of the deal. The paper’s sources did, however, divulge that Isomorphic is eyeing a valuation of between $40 billion and $50 billion. […]
The post Alphabet spinoff Isomorphic Labs reportedly raising funding at up to $50B valuation appeared first on SiliconANGLE.
